Vice President, Asset Lead Oniyvde & Oncology Portfolio Strategy

Title:

Vice President, Asset Lead Oniyvde & Oncology Portfolio Strategy

Company:

Ipsen Bioscience, Inc.

Job Description:

Summary / purpose of the position

As the Oniyvde Asset Lead, he/she is accountable for maximizing and delivering Oniyvde value targets. He/she will lead a cross-functional Global Oniyvde Asset Team to successfully define and deliver the integrated asset strategy and development and commercial plans in close collaboration with Global R&D, Tech Ops and Alliances divisions, GPPS, and Affiliates during a period of Oniyvde life cycle.

As the Oncology Portfolio Strategy head, he/she in collaboration with Head of NPP & Strategy, R&D, GMA and BD co-leads the strategic planning and execution of our oncology portfolio . He/she plays a critical role in driving the growth and success of our oncology pipeline, ensuring alignment with Ipsen strategy, and maximizing the value of our oncology assets.

Main responsibilities / job expectations

As Oniyvde Asset Lead :

Define and deliver an integrated asset strategy and plan for Oniyvde to address patient needs

• Create scientific and commercial value from development to commercialization, from late development phase to patent expiry; own the overall program strategy, establishes project goals and leads a cross-functional team to meet the program objectives

• Outline an integrated development strategy that shapes the competitive and prescription landscape including BD opportunity that could grow the asset

• Translate the strategy into an efficiently executable high-level roadmap with clear priorities and oversee operations, ensure a strong alignment with all functions, and drive operational excellence in execution, is accountable for achieving agreed upon milestones and KPIs for asset with support of a project manager.

• Identify opportunities through bold and disruptive leadership, starting with a vision translated into robust planning based on internal and external insights.

• Set short- and long-term product strategy and operational priorities within corporate priorities. Accountable for driving and coordination of development, registration, launch and market facing activities and LCM according to product strategy and set on a course to maximize both near- and long-term value. Lead communication platform across all key internal and external stakeholders.

• With the support of a strong project manager, ensures that a comprehensive risk mitigation plan is maintained and implemented to address potential risk to the Asset

• Maintains good scientific, technical and clinical expertise in the specific therapeutic area. Critically reads and evaluates relevant medical literature with good understanding of the data and deep status from competitive products and with said knowledge develop a life cycle management strategy.

Integrates and create a high performing Asset team to execute the Asset strategy:

• Lead the cross-functional Global "Asset" Team to build the vision and strategy to maximize value of the "Asset"

• Together with functions, outlines the resource and internal/external needs for the 5Y plan, to ensure the right allocation of efforts and resources to maximize value and to challenge resource allocation across functions

• Builds and effectively leads high performing and motivated cross-functional teams and succeeds through authentic leadership at the highest levels

• Together with each function head, sets objectives for the dedicated members of the Global "Asset" Team and assesses individual performance for objectives linked to the asset

• Create a continuous improvement mindset and finds innovative ways of working and creating a constant learning environment leveraged through benchmarking (e.g.: bold regulatory strategies, open-innovation partnership, competitive intelligence)

Manage Asset budget

• Oversee the Asset budget, from planning and reporting

• Manage projects prioritization within the budget 

• Provide strong insights for arbitration within the activities

As the Head of Oncology Portfolio Strategy:

Co-define and deliver an Oncology Portfolio Strategy in collaboration with other Ipsen divisions such as NPP & Strategy, R&D, GMA & BD ensuring alignment with the overall Ipsen strategy

• Part of the Oncology Leader